Supporting Breakthroughs in Autoimmune Disease Research at Pharmidex
January 19, 2026

Pharmidex is proud to offer comprehensive in vitro and preclinical solutions tailored to autoimmune disease research, helping accelerate the development of novel treatments.


Our expertise spans multiple autoimmune indications including multiple sclerosis, psoriasis, atopic dermatitis, alopecia, colitis, immune response and vitiligo, combining rigorous proof-of-concept studies with integrated pharmacokinetic, pharmacodynamic, biomarkers analysis, histopathological evaluation of relevant organs and tissues, toxicological and bioanalytical endpoints to support fast-track research.


With deep scientific knowledge and flexible study designs, we partner with researchers to deliver translationally relevant data that informs confident decision-making throughout the drug discovery and development pathway.


If your team is advancing immune-modulating therapies, we’d be delighted to discuss how Pharmidex can help support your research.


🌐 www.pharmidex.com

March 4, 2026
🔬 Unlock deeper insights into how your compound is processed in the body with Pharmidex ’s Drug Metabolism Services. At Pharmidex , we provide specialist drug metabolism studies using advanced UHPLC-high resolution/accurate mass spectrometry to support biotransformation understanding, cross-species metabolite profiling and structural characterisation of metabolites. Our expert team can help you address challenges such as high clearance, identification of metabolically labile sites and potential reactive metabolism liabilities, helping you make data-driven decisions early in the discovery and development process. Learn how our tailored approach can strengthen your metabolic profiling and accelerate your drug development programmes: 🔗 https://www.pharmidex.com/Drug-Metabolism-Service
February 26, 2026
At Pharmidex , we deliver industry-leading Discovery Bioanalysis services grounded in advanced LC-MS technologies to enhance drug discovery and preclinical research, supporting internal studies but also analyzing external samples also Our experienced bioanalytical team works across a wide range of therapeutic modalities, from small molecules and peptides, to oligonucleotides and complex biologics, providing robust, reliable and fit-for-purpose data to accelerate your program and strengthen decision-making during early development. We support both non-GLP and GLP/GCP workflows, method development, validation, and quantitative analysis that align with regulatory needs and industry expectations. Learn more about how our LC-MS capabilities can help you confidently advance your projects: 🔗 https://www.pharmidex.com/Discovery-Bioanalysis
February 24, 2026
Today we took a short pause from the science to enjoy some well-deserved donuts together in the office. At Pharmidex , we believe culture matters just as much as capability. Moments like this simple, informal, and inclusive are part of what keeps our team connected and motivated. As a preclinical CRO, we support over 400 clients each year from our UK laboratories, delivering high-quality in vivo and bioanalytical services to advance drug discovery programmes.  A small break. A strong team. Back to delivering great science. If we can support your next drug discovery project, do get in touch.
More Posts